Skip to main content

Advertisement

Springer Nature Link
Log in

Familial and acquired hemophagocytic lymphohistiocytosis

  • Review
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition of severe hyperinflammation caused by the uncontrolled proliferation of activated lymphocytes and histiocytes secreting high amounts of inflammatory cytokines. Cardinal signs and symptoms are prolonged fever, hepatosplenomegaly and pancytopenia. Characteristic biochemical markers include elevated triglycerides, ferritin and low fibrinogen. HLH occurs on the basis of various inherited or acquired immune deficiencies. Impaired function of natural killer (NK) cells and cytotoxic T-cells (CTL) is shared by all forms of HLH. Genetic HLH occurs in familial forms (FHLH) in which HLH is the primary and only manifestation, and in association with the immune deficiencies Chédiak-Higashi syndrome 1 (CHS 1), Griscelli syndrome 2 (GS 2) and x-linked lymphoproliferative syndrome (XLP), in which HLH is a sporadic event. Most patients with acquired HLH have no known underlying immune deficiency. Both acquired and genetic forms are triggered by infections, mostly viral, or other stimuli. HLH also occurs as a complication of rheumatic diseases (macrophage activation syndrome) and of malignancies. Several genetic defects causing FHLH have recently been discovered and have elucidated the pathophysiology of HLH. The immediate aim of therapy in genetic and acquired HLH is suppression of the severe hyperinflammation, which can be achieved with immunosuppressive/immunomodulatary agents and cytostatic drugs. Patients with genetic forms have to undergo stem cell transplantation to exchange the defective immune system with normally functioning immune effector cells.

In conclusion, awareness of the clinical symptoms and of the diagnostic criteria of HLH is crucial in order not to overlook HLH and to start life-saving therapy in time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CHS 1:

Chédiak-Higashi syndrome 1

CSF:

cerebrospinal fluid

CNS:

central nervous system

CTL:

cytotoxic T lymphocyte

EBV:

Epstein-Barr virus

FHLH:

familial hemophagocytic lymphohistiocytosis

GS 2:

Griscelli syndrome 2

HLH:

hemophagocytic lymphohistiocytosis

IAHS:

infection-associated hemophagocytic syndrome

IL:

interleukin

INF-γ:

interferon γ

LAHS:

lymphoma-associated hemophagocytic syndrome

MIP1-α:

macrophage inflammatory protein 1-α

MRT:

magnetic resonance tomography

NK cell:

natural killer cell

sCD25:

α-chain of the soluble interleukin-2 receptor

SCT:

stem cell transplantation

sJRA:

systemic-onset juvenile rheumatoid arthritis

TNF-α:

tumor necrosis factor α

VAHS:

virus-associated hemophagocytic syndrome

XLP:

x-linked lymphoproliferative syndrome

References

  1. Allen M, De Fusco C, Legrand F, Clementi R, Conter V, Danesino C, Janka G, Arico M (2001) Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica 86:499–503

    PubMed  CAS  Google Scholar 

  2. Almousa H, Ouachee-Chardin M, Picard C, Radford-Weiss I, Caillat-Zucman S, Cavazzana-Calvo M, Blanche S, de Saint Basile G, Le Deist F, Fischer A (2005) Transient familial haemophagocytic lymphohistiocytosis reactivation post-CD34 haematopoietic stem cell transplantation. Br J Haematol 130:404–408

    PubMed  CAS  Google Scholar 

  3. Ambruso DR, Hays T, Zwartjes WJ, Tubergen DG, Favara BE (1980) Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213. Cancer 45:2516–2520

    PubMed  CAS  Google Scholar 

  4. Arico M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, Martinetti M, Rusca MP (1996) Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 10:197–203

    PubMed  CAS  Google Scholar 

  5. Arico M, Nespoli L, Maccario R, Montagna D, Bonetti F, Caselli D, Burgio GR (1988) Natural cytotoxicity impairment in familial haemophagocytic lymphohistiocytosis. Arch Dis Child 63:292–296

    PubMed  CAS  Google Scholar 

  6. Baker KS, DeLaat CA, Steinbuch M, Gross TG, Shapiro RS, Loechelt B, Harris R, Filipovich AH (1997) Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood 89:3857–3863

    PubMed  CAS  Google Scholar 

  7. Bejaoui M, Veber F, Girault D, Gaud C, Blanche S, Griscelli C, Fischer A (1989) The accelerated phase of Chediak-Higashi syndrome. Arch Fr Pediatr 46:733–736

    PubMed  CAS  Google Scholar 

  8. Beutel K, Janka GE, Schneider ME (2002) EBV-associated hemophagocytic lymphohistiocytosis (HLH) in German children. Med Pediatr Oncol 38:224

    Google Scholar 

  9. Blanche S, Caniglia M, Girault D, Landman J, Griscelli C, Fischer A (1991) Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-center study of 22 cases. Blood 78:51–54

    PubMed  CAS  Google Scholar 

  10. Chen R, Relouzat F, Roncagalli R, Aoukaty A, Tan R, Latour S, Veillette A (2004) Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors. Mol Cell Biol 24:5144–5156

    PubMed  CAS  Google Scholar 

  11. Chuang HC, Lay JD, Hsieh WC, Wang HC, Chang Y, Chuang SE, Su IJ (2005) Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood 106:3090–3096

    PubMed  CAS  Google Scholar 

  12. Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C, Arico M (2002) Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 100:2266–2267

    PubMed  CAS  Google Scholar 

  13. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Wray P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, de St Basile G, Jones A, Behloradsky BH, Achatz H, Murken J, Fassler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20:129–135

    PubMed  CAS  Google Scholar 

  14. Cooper N, Rao K, Gilmour K, Hadad L, Adams S, Cale C, Davies G, Webb D, Veys P, Amrolia P (2006) Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. Blood 107:1233–1236

    PubMed  CAS  Google Scholar 

  15. Dürken M, Horstmann M, Bieling P, Erttmann R, Kabisch H, Loliger C, Schneider EM, Hellwege HH, Kruger W, Kroger N, Zander AR, Janka GE (1999) Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients. Br J Haematol 106:1052–1058

    PubMed  CAS  Google Scholar 

  16. Duval M, Fenneteau O, Doireau V, Faye A, Emilie D, Yotnda P, Drapier JC, Schlegel N, Sterkers G, de Baulny HO, Vilmer E (1999) Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr 134:236–239

    PubMed  CAS  Google Scholar 

  17. Eife R, Janka GE, Belohradsky BH, Holtmann H (1989) Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatr Hematol Oncol 6:265–272

    Article  PubMed  CAS  Google Scholar 

  18. Falini B, Pileri S, De Solas I, Martelli MF, Mason DY, Delsol G, Gatter KC, Fagioli M (1990) Peripheral T-cell lymphoma associated with hemophagocytic syndrome. Blood 75:434–444

    PubMed  CAS  Google Scholar 

  19. Farquhar JW, Claireaux AE (1952) Familial haemophagocytic reticulosis. Arch Dis Child 27:519–525

    PubMed  CAS  Google Scholar 

  20. Favara BE (1996) Histopathology of the liver in histiocytosis syndromes. Pediatr Pathol Lab Med 16:413–433

    PubMed  CAS  Google Scholar 

  21. Feldmann J, Callebaut I, Raposo G, Certain S, Bacq D, Dumont C, Lambert N, Ouachee-Chardin M, Chedeville G, Tamary H, Minard-Colin V, Vilmer E, Blanche S, Le Deist F, Fischer A, de Saint Basile G (2003) Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115:461–473

    PubMed  CAS  Google Scholar 

  22. Feldmann J, Menasche G, Callebaut I, Minard-Colin V, Bader-Meunier B, Le Clainche L, Fischer A, Le Deist F, Tardieu M, de Saint Basile G (2005) Severe and progressive encephalitis as a presenting manifestation of a novel missense perforin mutation and impaired cytolytic activity. Blood 105:2658–2663

    PubMed  CAS  Google Scholar 

  23. Ferlazzo G, Munz C (2004) NK cell compartments and their activation by dendritic cells. J Immunol 172:1333–1339

    PubMed  CAS  Google Scholar 

  24. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L (1999) Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5:405–411

    PubMed  CAS  Google Scholar 

  25. Filipovich A (2002) Hemophagocytic lymphohistiocytosis. Immunol Allergy Clin N Am 22:281–300

    Google Scholar 

  26. Filipovich AH (2005) Life-threatening hemophagocytic syndromes: current outcomes with hematopoietic stem cell transplantation. Pediatr Transplant 9 Suppl 7:87–91

    PubMed  Google Scholar 

  27. Fischer A, Cerf-Bensussan N, Blanche S, Le Deist F, Bremard-Oury C, Leverger G, Schaison G, Durandy A, Griscelli C (1986) Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 108:267–270

    PubMed  CAS  Google Scholar 

  28. Fitzgerald NE, McClain KL (2003) Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatr Radiol 33:392–401

    PubMed  Google Scholar 

  29. Fruman DA, Burakoff SJ, Bierer BE (1994) Immunophilins in protein folding and immunosuppression. Faseb J 8:391–400

    PubMed  CAS  Google Scholar 

  30. Gagnaire MH, Galambrun C, Stephan JL (2000) Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children–a series of 12 cases. Pediatrics 106:E58

    PubMed  CAS  Google Scholar 

  31. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O’Shea JJ, Chrousos GP, Bornstein SR (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. Faseb J 16:61–71

    PubMed  CAS  Google Scholar 

  32. Gilbert EF, ZuRhein GM, Wester SM, Herrmann J, Hong R, Opitz JM (1985) Familial hemophagocytic lymphohistiocytosis: report of four cases in two families and review of the literature. Pediatr Pathol 3:59–92

    PubMed  CAS  Google Scholar 

  33. Goldberg J, Nezelof C (1986) Lymphohistiocytosis: a multi-factorial syndrome of macrophagic activation clinico-pathological study of 38 cases. Hematol Oncol 4:275–289

    PubMed  CAS  Google Scholar 

  34. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A (2003) Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 142:292–296

    PubMed  CAS  Google Scholar 

  35. Hadchouel M, Prieur AM, Griscelli C (1985) Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr 106:561–566

    PubMed  CAS  Google Scholar 

  36. Haddad E, Sulis ML, Jabado N, Blanche S, Fischer A, Tardieu M (1997) Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood 89:794–800

    PubMed  CAS  Google Scholar 

  37. Hasegawa D, Kojima S, Tatsumi E, Hayakawa A, Kosaka Y, Nakamura H, Sako M, Osugi Y, Nagata S, Sano K (1998) Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 91:2793–2799

    PubMed  CAS  Google Scholar 

  38. Henter JI, Andersson B, Elinder G, Jakobson A, Lubeck PO, Soder O (1996) Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonists in hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 27:21–25

    PubMed  CAS  Google Scholar 

  39. Henter JI, Ehrnst A, Andersson J, Elinder G (1993) Familial hemophagocytic lymphohistiocytosis and viral infections. Acta Paediatr 82:369–372

    PubMed  CAS  Google Scholar 

  40. Henter JI, Elinder G (1992) Cerebromeningeal haemophagocytic lymphohistiocytosis. Lancet 339:104–107

    PubMed  CAS  Google Scholar 

  41. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U (1991) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 78:2918–2922

    PubMed  CAS  Google Scholar 

  42. Henter JI, Elinder G, Soder O, Ost A (1991) Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 80:428–435

    PubMed  CAS  Google Scholar 

  43. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100:2367–2373

    PubMed  CAS  Google Scholar 

  44. Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, Harada M (2006) Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol 81:59–61

    PubMed  Google Scholar 

  45. Herlin T, Pallesen G, Kristensen T, Clausen N (1987) Unusual immunophenotype displayed by histiocytes in haemophagocytic lymphohistiocystosis. J Clin Pathol 40:1413–1417

    PubMed  CAS  Google Scholar 

  46. Hibi S, Ikushima S, Fujiwara F, Hashida T, Tsunamoto K, Todo S, Imashuku S (1995) Serum and urine beta-2-microglobulin in hemophagocytic syndrome. Cancer 75:1700–1705

    PubMed  CAS  Google Scholar 

  47. Horne A, Zheng C, Lorenz I, Löfstedt M, Montgomery SM, Janka G, Henter J-I, Schneider EM (2005) Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocytic lymphohistiocytosis provides therapeutic guidance. Br J Haematol 129:658–666

    PubMed  Google Scholar 

  48. Horne A, Janka G, Maarten Egeler R, Gadner H, Imashuku S, Ladisch S, Locatelli F, Montgomery SM, Webb D, Winiarski J, Filipovich AH, Henter JI (2005) Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 129:622–630

    PubMed  Google Scholar 

  49. Howells DW, Strobel S, Smith I, Levinsky RJ, Hyland K (1990) Central nervous system involvement in the erythrophagocytic disorders of infancy: the role of cerebrospinal fluid neopterins in their differential diagnosis and clinical management. Pediatr Res 28:116–119

    PubMed  CAS  Google Scholar 

  50. Ikeda H, Kato M, Matsunaga A, Shimizu Y, Katsuura M, Hayasaka K (1998) Multiple sulphatase deficiency and haemophagocytic syndrome. Eur J Pediatr 157:553–554

    PubMed  CAS  Google Scholar 

  51. Imashuku S (2002) Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44:259–272

    PubMed  Google Scholar 

  52. Imashuku S, Hibi S, Tabata Y, Sako M, Sekine Y, Hirayama K, Sakazaki H, Maeda N, Kito H, Shichino H, Mugishima H (1998) Biomarker and morphological characteristics of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 31:131–137

    PubMed  CAS  Google Scholar 

  53. Imashuku S, Hibi S, Todo S, Sako M, Inoue M, Kawa K, Koike K, Iwai A, Tsuchiya S, Akiyama Y, Kotani T, Kawamura Y, Hirosawa M, Hasegawa D, Kosaka Y, Yamaguchi H, Ishii E, Kato K, Ishii M, Kigasawa H (1999) Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 23:569–572

    PubMed  CAS  Google Scholar 

  54. Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, Sako M, Hibi S (2001) Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 19:2665–2673

    PubMed  CAS  Google Scholar 

  55. Ishikawa J, Maeda T, Miyazaki T, Manabe N, Honda S, Nishiura T, Tomiyama Y, Matsuzawa Y (2000) Early onset of hemophagocytic syndrome following allogeneic bone marrow transplantation. Int J Hematol 72:243–246

    PubMed  CAS  Google Scholar 

  56. Jaffe ES, Costa J, Fauci AS, Cossman J, Tsokos M (1983) Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. Am J Med 75:741–749

    PubMed  CAS  Google Scholar 

  57. Janka G, Müller-Rosenberger, M, Schneider, EM (2001) Persistent defect of cellular cytotoxicity after Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Blood 96:36b

    Google Scholar 

  58. Janka G, Henter, J-I, Imashuku S (2005) Clinical aspects and therapy of hemophagocytic lymphohistiocytosis. In: Weitzman S, Egeler RM (ed) Histiocytic disorders of children and adults. Cambridge University Press, Cambridge, pp 353–379

    Google Scholar 

  59. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI (1998) Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 12:435–444

    PubMed  CAS  Google Scholar 

  60. Janka GE (1983) Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 140:221–230

    PubMed  CAS  Google Scholar 

  61. Janka GE, Schneider EM (2004) Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 124:4–14

    PubMed  Google Scholar 

  62. Jordan MB, Hildeman D, Kappler J, Marrack P (2004) An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 104:735–743

    PubMed  CAS  Google Scholar 

  63. Kapelari K, Fruehwirth M, Heitger A, Konigsrainer A, Margreiter R, Simma B, Offner FA (2005) Loss of intrahepatic bile ducts: an important feature of familial hemophagocytic lymphohistiocytosis. Virchows Arch 446:619–625

    PubMed  CAS  Google Scholar 

  64. Katano H, Cohen JI (2005) Perforin and lymphohistiocytic proliferative disorders. Br J Haematol 128:739–750

    PubMed  CAS  Google Scholar 

  65. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, Hanada R, Kinoshita A, Sakurai M, Kobayashi N et al (1993) Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 92:1444–1450

    Article  PubMed  CAS  Google Scholar 

  66. Kieslich M, Vecchi M, Driever PH, Laverda AM, Schwabe D, Jacobi G (2001) Acute encephalopathy as a primary manifestation of haemophagocytic lymphohistiocytosis. Dev Med Child Neurol 43:555–558

    PubMed  CAS  Google Scholar 

  67. Kikuta H, Sakiyama Y (1995) Etoposide (VP-16) inhibits Epstein-Barr virus determined nuclear antigen (EBNA) synthesis. Br J Haematol 90:971–973

    PubMed  CAS  Google Scholar 

  68. Klein C, Philippe N, Le Deist F, Fraitag S, Prost C, Durandy A, Fischer A, Griscelli C (1994) Partial albinism with immunodeficiency (Griscelli syndrome). J Pediatr 125:886–895

    PubMed  CAS  Google Scholar 

  69. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH (2002) Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 99:61–66

    PubMed  CAS  Google Scholar 

  70. Kollias SS, Ball WS Jr, Tzika AA, Harris RE (1994) Familial erythrophagocytic lymphohistiocytosis: neuroradiologic evaluation with pathologic correlation. Radiology 192:743–754

    PubMed  CAS  Google Scholar 

  71. Komp DM, McNamara J, Buckley P (1989) Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes. Blood 73:2128–2132

    PubMed  CAS  Google Scholar 

  72. Levy J, Wodell RA, August CS, Bayever E (1990) Adenovirus-related hemophagocytic syndrome after bone marrow transplantation. Bone Marrow Transplant 6:349–352

    PubMed  CAS  Google Scholar 

  73. Loechelt BJ, Egeler M, Filipovich AH, Jyonouchi H, Shapiro RS (1994) Immunosuppression: preliminary results of alternative maintenance therapy for familial hemophagocytic lymphohistocytosis (FHL). Med Pediatr Oncol 22:325–328

    PubMed  CAS  Google Scholar 

  74. Menasche G, Feldmann J, Fischer A, de Saint Basile G (2005) Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 203:165–179

    PubMed  CAS  Google Scholar 

  75. Menasche G, Pastural E, Feldmann J, Certain S, Ersoy F, Dupuis S, Wulffraat N, Bianchi D, Fischer A, Le Deist F, de Saint Basile G (2000) Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat Genet 25:173–176

    PubMed  CAS  Google Scholar 

  76. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, Mingari MC, Biassoni R, Moretta L (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19:197–223

    PubMed  CAS  Google Scholar 

  77. Moretta L, Ferlazzo G, Mingari MC, Melioli G, Moretta A (2003) Human natural killer cell function and their interactions with dendritic cells. Vaccine 21 Suppl 2:S38–42

    PubMed  Google Scholar 

  78. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM (1996) Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr 129:750–754

    PubMed  CAS  Google Scholar 

  79. Mroczek EC, Weisenburger DD, Grierson HL, Markin R, Purtilo DT (1987) Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 111:530–535

    PubMed  CAS  Google Scholar 

  80. Müller-Rosenberger M (2004) Histiozytyäre Hämophagozytosesyndrome bei Kindern; Klinik, Verlauf und funktionelle Diagnostik. Dissertation University Hamburg, Hamburg

  81. Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ, McGrail SH, Dussault BJ Jr, Perou CM, Boissy RE, Duyk GM, Spritz RA, Moore KJ (1996) Identification and mutation analysis of the complete gene for Chediak-Higashi syndrome. Nat Genet 14:307–311

    PubMed  CAS  Google Scholar 

  82. Neeft M, Wieffer M, de Jong AS, Negroiu G, Metz CH, van Loon A, Griffith J, Krijgsveld J, Wulffraat N, Koch H, Heck AJ, Brose N, Kleijmeer M, van der Sluijs P (2005) Munc13-4 is an effector of rab27a and controls secretion of lysosomes in hematopoietic cells. Mol Biol Cell 16:731–741

    PubMed  CAS  Google Scholar 

  83. Ohadi M, Lalloz MR, Sham P, Zhao J, Dearlove AM, Shiach C, Kinsey S, Rhodes M, Layton DM (1999) Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. Am J Hum Genet 64:165–171

    PubMed  CAS  Google Scholar 

  84. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, Ohta H, Fujisaki H, Kobayashi M, Sakata N, Kawa-Ha K, Okada S, Tawa A (1997) Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 89:4100–4103

    PubMed  CAS  Google Scholar 

  85. Ouachee-Chardin M, Elie C, de Saint Basile G, Le Deist F, Mahlaoui N, Picard C, Neven B, Casanova JL, Tardieu M, Cavazzana-Calvo M, Blanche S, Fischer A (2006) Hematopoietic stem cell transplantation in hemophagocytic lymphohistiocytosis: a single-center report of 48 patients. Pediatrics 117:e743–e750

    PubMed  Google Scholar 

  86. Parizhskaya M, Reyes J, Jaffe R (1999) Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 2:360–366

    PubMed  CAS  Google Scholar 

  87. Perel Y, Alos N, Ansoborlo S, Carrere A, Guillard JM (1997) Dramatic efficacy of antithymocyte globulins in childhood EBV-associated haemophagocytic syndrome. Acta Paediatr 86:911

    Article  PubMed  CAS  Google Scholar 

  88. Perez N, Virelizier JL, Arenzana-Seisdedos F, Fischer A, Griscelli C (1984) Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr 104:569–573

    PubMed  CAS  Google Scholar 

  89. Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, Martelli MF, Rivano MT, Mason DY, Stansfeld AG (1990) Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1 + with a high content of reactive histiocytes). Histopathology 16:383–391

    PubMed  CAS  Google Scholar 

  90. Poggi A, Costa P, Tomasello E, Moretta L (1998) IL-12-induced up-regulation of NKRP1A expression in human NK cells and consequent NKRP1A-mediated down-regulation of NK cell activation. Eur J Immunol 28:1611–1616

    PubMed  CAS  Google Scholar 

  91. Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA (2001) Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 28:2120–2124

    PubMed  CAS  Google Scholar 

  92. Purtilo DT, Grierson HL, Davis JR, Okano M (1991) The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975–1990. Pediatr Pathol 11:685–710

    PubMed  CAS  Google Scholar 

  93. Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, Sorbara L, Raffeld M, Straus SE, Jaffe ES (2000) Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 96:443–451

    PubMed  CAS  Google Scholar 

  94. Ramanan A, Laxer R, Schneider R (2005) Secondary hemophagocytic syndromes associated with rheumatic diseases. In: Weitzman S ER (ed) Histiocytic disorders of children and adults. Cambridge University Press, Cambridge, pp 380–395

    Google Scholar 

  95. Ravelli A (2002) Macrophage activation syndrome. Curr Opin Rheumatol 14:548–552

    PubMed  CAS  Google Scholar 

  96. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, Viola S, Martini A (2005) Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 146:598–604

    PubMed  Google Scholar 

  97. Reardon DA, Roskos R, Hanson CA, Castle V (1991) Virus-associated hemophagocytic syndrome following bone marrow transplantation. Am J Pediatr Hematol Oncol 13:305–309

    Article  PubMed  CAS  Google Scholar 

  98. Reiner AP, Spivak JL (1988) Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) 67:369–388

    CAS  Google Scholar 

  99. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, Brunning RD (1979) Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993–1002

    PubMed  CAS  Google Scholar 

  100. Risma KA, Frayer RW, Filipovich AH, Sumegi J (2006) Aberrant maturation of mutant perforin underlies the clinical diversity of hemophagocytic lymphohistiocytosis. J Clin Invest 116:182–192

    PubMed  CAS  Google Scholar 

  101. Ross C, Svenson M, Nielsen H, Lundsgaard C, Hansen MB, Bendtzen K (1997) Increased in vivo antibody activity against interferon alpha, interleukin-1alpha, and interleukin-6 after high-dose Ig therapy. Blood 90:2376–2380

    PubMed  CAS  Google Scholar 

  102. Schneider EM, Lorenz I, Muller-Rosenberger M, Steinbach G, Kron M, Janka-Schaub GE (2002) Hemophagocytic lymphohistiocytosis is associated with deficiencies of cellular cytolysis but normal expression of transcripts relevant to killer-cell-induced apoptosis. Blood 100:2891–2898

    PubMed  CAS  Google Scholar 

  103. Schneider EM, Lorenz I, Walther P, Janka-Schaub GE (2003) Natural killer deficiency: a minor or major factor in the manifestation of hemophagocytic lymphohistiocytosis? J Pediatr Hematol Oncol 25:680–683

    PubMed  Google Scholar 

  104. Schneider P, Greene V, Kanold J, Vannier JP (2001) Fludarabine in the treatment of an active phase of a familial haemophagocytic lymphohistiocytosis. Arch Dis Child 84:373

    PubMed  CAS  Google Scholar 

  105. Shiflett SL, Kaplan J, Ward DM (2002) Chediak-Higashi Syndrome: a rare disorder of lysosomes and lysosome related organelles. Pigment Cell Res 15:251–257

    PubMed  CAS  Google Scholar 

  106. Shinoda J, Murase S, Takenaka K, Sakai N (2005) Isolated central nervous system hemophagocytic lymphohistiocytosis: case report. Neurosurgery 56:187

    PubMed  Google Scholar 

  107. Stephan JL, Donadieu J, Ledeist F, Blanche S, Griscelli C, Fischer A (1993) Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 82:2319–2323

    PubMed  CAS  Google Scholar 

  108. Stephan JL, Kone-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM (2001) Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 40:1285–1292

    CAS  Google Scholar 

  109. Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM (1993) Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 11:451–456

    PubMed  CAS  Google Scholar 

  110. Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286:1957–1959

    PubMed  CAS  Google Scholar 

  111. Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55–59

    PubMed  CAS  Google Scholar 

  112. Sullivan KE, Delaat CA, Douglas SD, Filipovich AH (1998) Defective natural killer cell function in patients with hemophagocytic lymphohistiocytosis and in first degree relatives. Pediatr Res 44:465–468

    PubMed  CAS  Google Scholar 

  113. Sumazaki R, Kanegane H, Osaki M, Fukushima T, Tsuchida M, Matsukura H, Shinozaki K, Kimura H, Matsui A, Miyawaki T (2001) SH2D1A mutations in Japanese males with severe Epstein-Barr virus-associated illnesses. Blood 98:1268–1270

    PubMed  CAS  Google Scholar 

  114. Takada H, Ohga S, Mizuno Y, Suminoe A, Matsuzaki A, Ihara K, Kinukawa N, Ohshima K, Kohno K, Kurimoto M, Hara T (1999) Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol 106:182–189

    PubMed  CAS  Google Scholar 

  115. Takei M, Ishiwata T, Mitamura K, Fujiwara S, Sasaki K, Nishi T, Kuga T, Ookubo T, Horie T, Ryu J, Ohi H, Sawada S (2001) Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. Int Immunol 13:559–565

    PubMed  CAS  Google Scholar 

  116. Teruya-Feldstein J, Setsuda J, Yao X, Kingma DW, Straus S, Tosato G, Jaffe ES (1999) MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. Lab Invest 79:1583–1590

    PubMed  CAS  Google Scholar 

  117. Tomaske M, Amon O, Bosk A, Handgretinger R, Schneider EM, Niethammer D (2002) Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 38:141–142

    PubMed  Google Scholar 

  118. Ueda I, Ishii E, Morimoto A, Ohga S, Sako M, Imashuku S (2006) Correlation between phenotypic heterogeneity and gene mutational characteristics in familial hemophagocytic lymphohistiocytosis (FHL). Pediatr Blood Cancer 46:482–488

    PubMed  Google Scholar 

  119. Villanueva J, Lee S, Giannini EH, Graham TB, Passo MH, Filipovich A, Grom AA (2005) Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 7:R30–R37

    PubMed  CAS  Google Scholar 

  120. Woltman AM, Massacrier C, de Fijter JW, Caux C, van Kooten C (2002) Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. J Immunol 168:6181–6188

    PubMed  CAS  Google Scholar 

  121. Wulffraat NM, Rijkers GT, Elst E, Brooimans R, Kuis W (2003) Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. Rheumatology (Oxford) 42:375–379

    CAS  Google Scholar 

  122. Zur Stadt U, Beutel K, Kolberg S, Schneppenheim R, Kabisch H, Janka G, Hennies HC (2006) Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A. Hum Mutat 27:62–68

    PubMed  Google Scholar 

  123. Zur Stadt U, Schmidt S, Kasper B, Beutel K, Diler AS, Henter JI, Kabisch H, Schneppenheim R, Nurnberg P, Janka G, Hennies HC (2005) Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 14:827–834

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Oncology, Children’s Hospital, University of Hamburg, Hamburg, Germany

    Gritta E. Janka

  2. Zentrum für Frauenheilkunde, Kinder- und Jugendmedizin, Klinik für Pädiatrische Hämatologie und Onkologie, Universitätskrankenhaus Eppendorf, Martinistrasse 20, 20246, Hamburg, Germany

    Gritta E. Janka

Authors
  1. Gritta E. Janka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gritta E. Janka.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janka, G.E. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 166, 95–109 (2007). https://doi.org/10.1007/s00431-006-0258-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-006-0258-1

Keywords

Search

Navigation